An Immune-Based Biomarker Signature is Associated with Mortality in COVID-19 Patients
Abers, Michael S., et al. JCI Insight, 24 November 2020.
An Immune-Based Biomarker Signature is Associated with Mortality in COVID-19 Patients Read More »
Publication
Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease
Audley J, Gliniewicz EF, Zarember KA, Hong HS, Wald G, Kuhns DB, Kang E, Malech HL, Suffredini AF, Noveck RJ, Dinubile MJ, Levinson SL, Stossel TP, Gallin JI. Inflammation. 2021 Feb;44(1):270-277. doi: 10.1007/s10753-020-01330-w. Epub 2020 Sep 4. PMID: 32886268; PMCID: PMC10825630.
Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease Read More »
Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas Aeruginosa Pneumonia.
DiNubile, Mark J, et al. Open Forum Infectious Disease, 19 June 2020.
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection
Messner, Christoph B., et al. Cell Systems, Cell Press, 2 June 2020.
Ultra-High-Throughput Clinical Proteomics Reveals Classifiers of COVID-19 Infection Read More »
Recombinant Human Plasma Gelsolin Stimulates Phagocytosis While Diminishing Excessive Inflammatory Responses in Mice with Pseudomonas Aeruginosa Sepsis.
Piktel, E., et al. Int. J. Mol. Sci., 4 April 2020
Gelsolin: A New Biomarker of Disease Activity in SLE Patients Associated with HDL-c
Parra S, Heras M, Herrero P, Amigó N, Garcés E, Girona J, Correig X, Canela N, Castro A. Rheumatology (Oxford). 2020 Mar 1;59(3):650-661. doi: 10.1093/rheumatology/kez293. PMID: 31504936.
Gelsolin: A New Biomarker of Disease Activity in SLE Patients Associated with HDL-c Read More »
Large-Scale Multi-Omic Analysis of COVID-19 Severity
Overmyer, Katherine A, et al. MedRxiv, Cold Spring Harbor Laboratory Press, 1 Jan. 2020.
Large-Scale Multi-Omic Analysis of COVID-19 Severity Read More »
Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Severe Influenza.
Yang, Zhiping, et al. F1000Research, F1000 Research Limited, 6 Nov. 2019.
Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia
Yang, Zhiping, et al. The Journal of Infectious Diseases, Oxford University Press, 26 Sept. 2019.
Low Admission Plasma Gelsolin Concentrations Identify Community-Acquired Pneumonia Patients at High Risk for Severe Outcomes
Self, Wesley H, et al. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America, Oxford University Press, 13 Sept. 2019.